Eli Lilly Logs Higher H1 Profit; Revenue Jumps
Wall Street Momentum Stalls After Thursday's Rally, Palantir Jumps To 3-Year Highs, Bonds Rally: What's Driving Markets Friday?
Expedia Posts Upbeat Earnings, Joins Akamai Technologies, Trade Desk, DXC Technology And Other Big Stocks Moving Higher On Friday
'Don't Overreact to Market Volatility': Strategist
Eli Lilly Price Target Raised to $1000.00/Share From $875.00 by Wells Fargo
Eli Lilly Named 'Top Pick' Following Q2 Beat, Upbeat Revenue Outlook, Morgan Stanley Says
Moovin Stonks | Friday Market Calm Before Storm After Turbulent Week
What Eli Lilly, Novo Nordisk Earnings Show About GLP-1 Sales
Analyzing Eli Lilly In Comparison To Competitors In Pharmaceuticals Industry
U.S. stock market anomaly | Weight loss concept stocks rise, Eli Lilly and Co (LLY.US) rose more than 6.8%.
As of press time, the stock rose more than 6.8%, reporting $903.
Redburn Atlantic Adjusts Eli Lilly Price Target to $640 From $600
S&P 500's Biggest Single-day Gain Proved Buying the Dip Was a Sound Strategy - GS's FICC and Equities
Express News | Eli Lilly Shares Are Trading Higher on Continued Strength After the Company on Thursday Reported Better-than-expected Q2 Financial Results and Raised Its Full-year Guidance. Multiple Analysts Raised Their Price Targets Following the Report
Eli Lilly Unusual Options Activity
Express News | Eli Lilly Shares up 3.9% After Several Brokerages Raise PT on Co Following Q2 Results
Jefferies Remains a Buy on Eli Lilly & Co (LLY)
Express News | Eli Lilly & Co. : Morgan Stanley Raises Target Price to $1106.00 From $1083.00
Eli Lilly Is Maintained at Outperform by BMO Capital
These Stocks Join Meta and Eli Lilly as the Biggest Winners This Earnings Season
Dividend Roundup: Prudential Financial, Progressive, Alcoa, Eli Lilly, and More